Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.47M Buy
12,222
+4,768
+64% +$932K 0.24% 135
2022
Q3
$1.31M Sell
7,454
-318
-4% -$65.1K 0.16% 191
2022
Q2
$1.56M Buy
7,772
+45
+0.6% +$9.59K 0.18% 191
2022
Q1
$1.75M Sell
7,727
-139
-2% -$32.7K 0.17% 193
2021
Q4
$2.12M Sell
7,866
-55
-0.7% -$13.6K 0.2% 159
2021
Q3
$1.92M Buy
7,921
+1,940
+32% +$489K 0.18% 170
2021
Q2
$1.42M Buy
5,981
+1,722
+40% +$392K 0.13% 245
2021
Q1
$933K Buy
4,259
+2,213
+108% +$444K 0.09% 331
2020
Q4
$357K Sell
2,046
-12
-0.6% -$2.07K 0.04% 495
2020
Q3
$333K Buy
2,058
+41
+2% +$6.5K 0.04% 482
2020
Q2
$288K Sell
2,017
-4,312
-68% -$597K 0.03% 500
2020
Q1
$76K Sell
6,329
-47
-0.7% -$6.77K 0.01% 588
2019
Q4
$927K Hold
6,376
0.1% 342
2019
Q3
$920K Hold
6,376
0.1% 334
2019
Q2
$947K Sell
6,376
-3,772
-37% -$526K 0.1% 328
2019
Q1
$1.33M Hold
10,148
0.13% 264
2018
Q4
$1.1M Buy
+10,148
New +$1.36M 0.15% 211

Other funds holding LH

Seeyond's LH Position: Q4 2022 in Review

Seeyond increased its Labcorp (LH) stake by 64% in Q4 2022, buying an estimated $932K and bringing the position to 12,222 shares worth $2.47M. The position accounts for 0.24% of the portfolio, ranked #135.

Seeyond first reported a position in LH in Q4 2018 and has held it in 17 quarters since. 970 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • Seeyond held 12,222 shares of Labcorp worth $2.47M as of Q4 2022.
  • Seeyond bought 4,768 Labcorp shares in Q4 2022, an estimated $932K.
  • Labcorp made up 0.24% of Seeyond's portfolio in Q4 2022, its #135 holding.
  • Seeyond first reported a position in Labcorp in Q4 2018 and has held it in 17 quarters since.
  • 970 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.